Materialise NV (MTLS) Stock Price & How to Invest

Materialise is a Belgian additive manufacturing company that combines 3D printing software, a large printing service bureau, and a medical device business making patient-specific surgical guides and implants.

Materialise is more diversified than a pure printer maker, with software and medical revenue alongside the service bureau. Verify current segment revenue and margins, which differ substantially between those businesses.

The general service-bureau business is competitive and price-sensitive, and printing capacity is not scarce. Medical revenue is regulated, so approvals and reimbursement decisions affect it directly. As a Belgian company reporting in euros, results are exposed to currency movements against the dollar. The additive industry overall has grown more slowly than forecast for a decade.

3 analysts publish price targets on MTLS, averaging $8.16 against a $6.35 price as of August 2026, or +28.5%. The published targets run from $6.66 to $9.79, a moderate spread, and the ratings split 3 buy, 0 hold, 0 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full MTLS forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Materialise NV. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Medical is the differentiated business. Materialise makes patient-specific surgical guides and implants from CT scans, a regulated business with clinical validation and hospital relationships behind it. The most optimistic published target, $9.79, assumes this works close to its best case.

The case against. The general service-bureau business is competitive and price-sensitive, and printing capacity is not scarce. The most pessimistic target, $6.66, is roughly what MTLS is worth if this bites instead.

Read the full bull and bear case on MTLS, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Materialise NV's investor relations page or your broker.

• Business model: Three segments: software licensing, printing services, medical devices
• Differentiator: Regulated patient-specific medical devices and cross-platform software
• Reporting currency: Euro, so dollar results move with FX
• Listing: US-listed ADS of a Belgian company

Materialise is more diversified than a pure printer maker, with software and medical revenue alongside the service bureau. Verify current segment revenue and margins, which differ substantially between those businesses.

These are the investment theses MTLS naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to MTLS: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get MTLS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so MTLS sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where MTLS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Materialise (MTLS) is best understood through the 3d printing theme it belongs to. Materialise is more diversified than a pure printer maker, with software and medical revenue alongside the service bureau. Verify current segment revenue and margins, which differ substantially between those businesses.

Whether MTLS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MTLS a buy or a sell?, and where the stock could go from here in the MTLS stock forecast.

For income investors, whether MTLS pays a dividend and how the payout looks is covered in does MTLS pay a dividend? And to weigh MTLS against a peer, read the full side-by-side comparisons: MTLS vs DDD and MTLS vs SSYS.